ATTO SCHEDULE 13D: SEC filing

Frazier Life Sciences entities

Filed with the SEC on · accession 0001231919-26-000857

ATTO filed a SCHEDULE 13D (schedule 13d) with the SEC on Aug 11, 2026. Frazier Life Sciences entities filed a joint filing agreement under Schedule 13D regarding their ownership of Attovia Therapeutics common stock. The stock moved -6.0% by the first close after the filing.

Summary of the filing

Frazier Life Sciences entities filed a joint filing agreement under Schedule 13D regarding their ownership of Attovia Therapeutics common stock. The filing indicates a group position in the company but provides no details on the size or purpose of the stake.

Key details

Reporting person / filerFrazier Life Sciences Public Fund, L.P.
General partner of frazier life sciences public fund, l.p.FHMLSP, L.P.
General partner of fhmlsp, l.p.FHMLSP, L.L.C.
Reporting person / filerFrazier Life Sciences XI, L.P.
General partner of frazier life sciences xi, l.p.FHMLS XI, L.P.
General partner of fhmls xi, l.p.FHMLS XI, L.L.C.
Reporting person / filerFrazier Life Sciences XII, L.P.
General partner of frazier life sciences xii, l.p.FHMLS XII, L.P.
General partner of fhmls xii, l.p.FHMLS XII, L.L.C.
IssuerAttovia Therapeutics, Inc.
Chief financial officerJennifer Martin

How ATTO stock reacted

Close before

$19.84

Aug 10, 2026

First close after

-6.00%

$18.65

5 trading days

+14.47%

$22.71

Since filing

-23.03%

$15.27

✦ Ask GOAX AI about this filing — what it means for ATTO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ATTO?

Click here

Frequently asked questions

What did ATTO file with the SEC on Aug 11, 2026?

ATTO filed a SCHEDULE 13D (SEC filing). Frazier Life Sciences entities filed a joint filing agreement under Schedule 13D regarding their ownership of Attovia Therapeutics common stock. The filing indicates a group position in the company but provides no details on the size or purpose of the stake.

How do I read a SCHEDULE 13D?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).

How did ATTO stock react to this filing?

ATTO closed at $19.84 before the filing and $18.65 on Aug 11, 2026 (-6.00%). Five trading days later: $22.71 (+14.47%).

Other ATTO SEC filings

Get alerts when ATTO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days